EDGAR Filing Documents for 0001485003-17-000078

Form 8-K - Current report:

SEC Accession No. 0001485003-17-000078

Filing Date

2017-08-14

Accepted

2017-08-14 07:30:33

Documents

Period of Report

2017-08-14

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	ebioform8kq22017earnings.htm	8-K	37466
2	EXHIBIT 99.1	q22017prvfinal.htm	EX-99.1	157262
3		ebiologoa23.jpg	GRAPHIC	89522
	Complete submission text file	0001485003-17-000078.txt		318991

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142

Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550

Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 171026884
SIC: 2834 Pharmaceutical Preparations